跳至主要内容
临床试验/2024-518293-13-01
2024-518293-13-01招募中2 期

Ventilation/Perfusion PET/CT with Galligas and 68Ga-MAA for regional lung function assessment after pulmonary embolism

Centre Hospitalier Regional Et Universitaire De Brest1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2025年1月28日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
32
试验地点
1
主要终点
Pulmonary vascular obstruction index (PVOI), expressed as a percentage of whole lung volume, on V/Q PET/CT imaging.

研究概览

简要总结

To assess the impact of PR on regional perfusion lung function with lung V/Q PET/CT imaging.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Patient treated with at least 3 months and up to 8 months of anticoagulation for an acute symptomatic PE diagnosed according the ESC and ACCP guidelines.
  • Patients who have a PembQol score ≥ 10% and whose total scores for the subgroups Q1 (dyspnea) and Q4 (impact of daily life) are ≥ 10%.
  • Patients planned to be randomized.
  • Abnormal conventional V/Q scan at V1
  • Give consent to participate to the EOLE study.

排除标准

  • Previsible inability to perform the effort test and/or PR
  • Cardiac insufficiency (unstable coronary artery disease)
  • Severe respiratory failure (long-term oxygen therapy, pulmonary hypertension)
  • Chronic dyspnea MMRC ≥ 2 before PE
  • Cardiac or respiratory rehabilitation in the previous year
  • Indication to urgent PR within 6 months at the time of inclusion
  • Life expectancy of less than 12 months
  • Inability to give consent
  • Patient under guardianship or curatorship
  • Patient deprived of liberty by an administrative or judicial decision
  • Patient has not social security affiliation or who don’t beneficiary of such social security
  • Presence of CTEPH according to international guidelines
  • Incapacity to perform the effort test
  • Effort test stopped because of hemodynamic intolerance
  • Cardiac failure discovered after PR work up
  • Patients treated for acute PE with anticoagulants for more than 8 months
  • Active cancer or in remission for less than two years
  • Dyspnea post – COVID due to parenchymal injuries
  • Post-COVID hyperventilation syndrome without pulmonary vascular perfusion sequelae
  • Physical or psychological inability to undertake PR
  • Isolated or more distal segmental PE
  • Neuro-muscular disease with PR contraindication.

结局指标

主要结局

Pulmonary vascular obstruction index (PVOI), expressed as a percentage of whole lung volume, on V/Q PET/CT imaging.

Pulmonary vascular obstruction index (PVOI), expressed as a percentage of whole lung volume, on V/Q PET/CT imaging.

次要结局

  • Global lung function parameters - Dyspnea scores : MDP, Borg and MMRC
  • V/Q PET/CT regional lung functional volumes : - pulmonary vascular obstruction index
  • V/Q PET/CT regional lung functional volumes : - pulmonary ventilation impairment index
  • Global lung function parameters - Respiratory functional tests (FVC, FEV, FVC-FEV) and TLco
  • Global lung function parameters - Cardio Pulmonary Exercise Tes
  • Global lung function parameters - Cycloergometer endurance tes
  • Global lung function parameters - 6MWT
  • Quality of life - PEmb-QoL score

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Clinical Trial Manager

Scientific

Centre Hospitalier Regional Et Universitaire De Brest

研究点 (1)

Loading locations...

相似试验